Editas Medicine, Inc.EDITNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank67
5Y CAGR-5.3%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-5.3%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 9.06% |
| 2024 | -55.16% |
| 2023 | 438.76% |
| 2022 | -34.73% |
| 2021 | 130.46% |
| 2020 | 11.92% |
| 2019 | -30.06% |
| 2018 | 15.43% |
| 2017 | -36.34% |
| 2016 | -195.79% |